Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 74 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Liver Cirrhosis  [Clear All Filters]
2020
Polyzos, S. A., Papaefthymiou A., Doulberis M., Katsinelos P., & Kountouras J. (2020).  Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited.. J Gastrointestin Liver Dis. 29(2), 270-271.
Boziki, M., Grigoriadis N., Doulberis M., Papaefthymiou A., Polyzos S. A., & Kountouras J. (2020).  Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis.. Dig Liver Dis. 52(1), 121-123.
Polyzos, S. A., Kountouras J., Goulas A., & Duntas L. (2020).  Selenium and selenoprotein P in nonalcoholic fatty liver disease.. Hormones (Athens). 19(1), 61-72.
2019
Polyzos, S. A., Slavakis A., Koumerkeridis G., Katsinelos P., & Kountouras J. (2019).  Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.. Horm Metab Res. 51(2), 134-140.
Stafylidou, M., Paschos P., Katsoula A., Malandris K., Ioakim K., Bekiari E., et al. (2019).  Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.. Clin Gastroenterol Hepatol. 17(9), 1744-1755.e11.
2018
Sousos, N., Sinakos E., Klonizakis P., Adamidou D., Daniilidis A., Gigi E., et al. (2018).  Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre.. Br J Haematol. 181(1), 140-142.
Kountouras, J., Polyzos S. A., Katsinelos P., Anastasiadis S., Tzivras D., Doulberis M., et al. (2018).  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.. Dig Dis Sci. 63(4), 1087-1088.
Hytiroglou, P., & Theise N. D. (2018).  Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.. Virchows Arch. 473(1), 15-22.
2017
Hadjihambi, A., De Chiara F., Hosford P. S., Habtetion A., Karagiannis A., Davies N., et al. (2017).  Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.. Hepatology. 65(4), 1306-1318.
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Lazaridis, N., & Tsochatzis E. (2017).  Current and future treatment options in non-alcoholic steatohepatitis (NASH).. Expert Rev Gastroenterol Hepatol. 11(4), 357-369.
Polyzos, S. A., Kountouras J., Mantzoros C. S., Polymerou V., & Katsinelos P. (2017).  Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.. Diabetes Obes Metab. 19(12), 1805-1809.
Kountouras, J., Polyzos S. A., Zeglinas C., & Katsinelos P. (2017).  Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease.. Liver Int. 37(7), 1082.
Spengler, E. K., O'Leary J. G., Te H. S., Rogal S., Pillai A. A., Al-Osaimi A., et al. (2017).  Liver Transplantation in the Obese Cirrhotic Patient.. Transplantation. 101(10), 2288-2296.
Chrysanthidis, T., Loli G., Metallidis S., & Germanidis G. (2017).  Mechanisms of accelerated liver fibrosis in HIV-HCV coinfection.. AIDS Rev. 19(3), 148-155.
Kalafateli, M., Zisimopoulos K., Vourli G., Rigamonti C., Goulis J., Manesis E., et al. (2017).  Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.. Dig Dis Sci. 62(5), 1363-1372.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Cholongitas, E., Goulis I., Ioannidou M., Soulaidopoulos S., Chalevas P., & Akriviadis E. (2017).  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.. Hepatol Int. 11(3), 306-314.
2016
Nadkarni, G. N., Simoes P. K., Patel A., Patel S., Yacoub R., Konstantinidis I., et al. (2016).  National trends of acute kidney injury requiring dialysis in decompensated cirrhosis hospitalizations in the United States.. Hepatol Int. 10(3), 525-31.
Cholongitas, E., Goulis I., Antoniadis N., Fouzas I., Imvrios G., Giakoustidis D., et al. (2016).  Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.. Transpl Infect Dis. 18(5), 667-673.
Kountouras, J., Polyzos S. A., Gavalas E., Boziki M., Katsinelos P., Zeglinas C., et al. (2016).  A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology.. J Gastrointestin Liver Dis. 25(3), 405-6.
Quaglia, A., Alves V. A., Balabaud C., Bhathal P. S., Bioulac-Sage P., Crawford J. M., et al. (2016).  Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.. Histopathology. 68(7), 953-67.
2015
Kountouras, J., Zavos C., Polyzos S. A., Katsinelos P., & Deretzi G. (2015).  Association between cirrhosis and Helicobacter pylori-related brain pathologies.. Eur J Gastroenterol Hepatol. 27(2), 183.
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.
Kountouras, J., Polyzos S. A., & Deretzi G. (2015).  Helicobacter pylori Associated With Obstructive Sleep Apnea Might Contribute to Sleep, Cognition, and Driving Performance Disturbances in Patients With Cirrhosis.. Clin Gastroenterol Hepatol. 13(8), 1547.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές